Journal article · 2026 · Open access

Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial

Ayal Aaron Aizer, Kee-Young Shin, Paul J. Catalano, Ivy Ricca, Marciana Johnson, Grant Benham, Kristin Röper, Beverly Spicer, Eileen Mann, Jennifer L. Nosker, Michael W. Parsons, Mallika L. Mendu and 13 more

JAMA, 335(13), 1127 · Published 19 February 2026 · DOI 10.1001/jama.2026.0076

Open full textView at the publisherCite this paper

In brief

“Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial” is a 2026 journal article by Ayal Aaron Aizer and 24 co-authors, published in JAMA. OpenAlex counts 55 citations as of 18 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
55
Most cited in
2026 (55)
Field-weighted impact
121.72
References
27
Authors
25

Abstract

Importance: Brain metastases are common in patients with cancer, and radiation is often used for management. Among patients with more than 4 brain metastases, the effects of stereotactic radiation targeting only individual tumors, compared with whole brain radiation with hippocampal avoidance, which radiates both tumors and normal brain, remain unknown. Objective: To determine whether stereotactic radiation improves symptom severity and interference with daily functioning, compared with whole brain radiation with hippocampal avoidance. Design, Setting, and Participants: Phase 3, open-label, randomized clinical trial conducted at 4 United States-based centers. Eligible patients had 5 to 20 brain metastases and no prior brain-directed radiation. Enrollment occurred between April 11, 2017, and May 17, 2024 (final follow-up, March 18, 2025). Intervention: Stereotactic radiation, compared with whole brain radiation with hippocampal avoidance. Main Outcomes and Measures: Mean weighted patient-reported symptom severity and interference score change over 6 months postbaseline relative to baseline using the MD Anderson Symptom Inventory-Brain Tumor instrument (scale, 0-10; score change range, -10 to 10; -10 = best). A clinically meaningful Δ was defined as 0.98. Results: Of 196 randomized patients (mean age, 61 years; 129 [66%] female; 176 [90%] White; median number of brain metastases, 14 [IQR, 11-18]; 49 [25%] with prior neurosurgical resection), 83 (42%) completed the 6-month assessment. For the primary outcome, between baseline and postbaseline assessments through the 6-month follow-up, stereotactic radiation changed the weighted composite MD Anderson Symptom Inventory-Brain Tumor score from 2.69 to 2.37 (mean change, -0.32) and hippocampal-avoidance whole brain radiation changed the score from 2.29 to 3.03 (mean change, 0.74) (mean difference, -1.06 [95% CI, -1.54 to -0.58]; P < .001). Related grade 3-5 adverse events occurred in 12 patients (12%) in the stereotactic radiation group and 13 patients (13%) in the hippocampal-avoidance whole brain radiation group; grade 1-3 fatigue was most frequent (27 [28%] vs 43 [44%], respectively). Conclusions and Relevance: In patients with 5 to 20 brain metastases, these findings support stereotactic radiation over hippocampal-avoidance whole brain radiation to improve symptoms and interference with daily functioning, key components of quality of life. Trial Registration: ClinicalTrials.gov Identifier: NCT03075072.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Aizer, A. A., Shin, K.-Y., Catalano, P. J., Ricca, I., Johnson, M., Benham, G., Röper, K., Spicer, B., Mann, E., Nosker, J. L., Parsons, M. W., Mendu, M. L., Hepel, J. T., Chipidza, F., Krishnan, M. S., Shi, D. D., Lamba, N., Pashtan, I. M., Peng, L., . . . Tanguturi, S. K. (2026). Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial. JAMA, 335(13), 1127. https://doi.org/10.1001/jama.2026.0076

MLA 9

Aizer, Ayal Aaron, et al. “Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial.” JAMA, vol. 335, no. 13, 2026, p. 1127. https://doi.org/10.1001/jama.2026.0076.

Chicago

Aizer, Ayal Aaron, Kee-Young Shin, Paul J. Catalano, Ivy Ricca, Marciana Johnson, Grant Benham, Kristin Röper, et al. 2026. “Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial.” JAMA 335 (13): 1127. https://doi.org/10.1001/jama.2026.0076.

Harvard

Aizer, A. A. et al. (2026) ‘Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial’, JAMA, 335(13), p. 1127. doi:10.1001/jama.2026.0076.

IEEE

A. A. Aizer et al., “Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial,” JAMA, vol. 335, no. 13, p. 1127, 2026, doi: 10.1001/jama.2026.0076.

BibTeX

@article{aizer2026treatment,
  title     = {{Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial}},
  author    = {Aizer, Ayal Aaron and Shin, Kee-Young and Catalano, Paul J. and Ricca, Ivy and Johnson, Marciana and Benham, Grant and Röper, Kristin and Spicer, Beverly and Mann, Eileen and Nosker, Jennifer L. and Parsons, Michael W. and Mendu, Mallika L. and Hepel, Jaroslaw T. and Chipidza, Fallon and Krishnan, Monica Shalini and Shi, Diana D. and Lamba, Nayan and Pashtan, Itai Max and Peng, Luke and Alexander, Brian Michael and Brown, Paul D. and Wen, Patrick Yung and Haas-Kogan, Daphne Adele and Rahman, Rifaquat M. and Tanguturi, Shyam Kumar},
  journal   = {JAMA},
  year      = {2026},
  volume    = {335},
  number    = {13},
  pages     = {1127},
  doi       = {10.1001/jama.2026.0076},
  url       = {https://doi.org/10.1001/jama.2026.0076}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Brain Metastases and Treatment

  • brain metastases
  • stereotactic radiosurgery
  • hippocampal avoidance
  • whole brain radiotherapy
  • patient-reported symptoms
  • symptom severity
  • MD Anderson Symptom Inventory
  • quality of life

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Aizer, A. A., Shin, K.-Y., Catalano, P. J., Ricca, I., Johnson, M., Benham, G., Röper, K., Spicer, B., Mann, E., Nosker, J. L., Parsons, M. W., Mendu, M. L., Hepel, J. T., Chipidza, F., Krishnan, M. S., Shi, D. D., Lamba, N., Pashtan, I. M., Peng, L., . . . Tanguturi, S. K. (2026). Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial. JAMA, 335(13), 1127. https://doi.org/10.1001/jama.2026.0076

How many times has this paper been cited?

55 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Ayal Aaron Aizer, Kee-Young Shin, Paul J. Catalano, Ivy Ricca, Marciana Johnson, Grant Benham, Kristin Röper, Beverly Spicer, Eileen Mann, Jennifer L. Nosker, Michael W. Parsons, Mallika L. Mendu and 13 more.

What is the DOI of this paper?

10.1001/jama.2026.0076, permanently at https://doi.org/10.1001/jama.2026.0076. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.